Intensity Therapeutics, Inc.
INTS
$1.85
-$0.01-0.54%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.59M | 2.78M | 6.32M | 10.50M | 14.78M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 773.00K | 1.01M | 1.12M | 672.00K | 688.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 3.36M | 3.79M | 7.44M | 11.17M | 15.46M |
|
|
|||||
| Total Current Assets | 3.36M | 3.79M | 7.44M | 11.17M | 15.46M |
| Net Property, Plant & Equipment | 122.00K | 128.00K | 135.00K | 141.00K | 147.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.30M | 1.30M | 1.10M | 1.10M | 1.68M |
| Total Assets | 4.78M | 5.21M | 8.67M | 12.41M | 17.30M |
|
|
|||||
| Total Accounts Payable | 1.22M | 540.00K | 1.92M | 1.22M | 3.05M |
| Total Accrued Expenses | 508.00K | 1.75M | 1.26M | 1.27M | 891.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 28.00K | 28.00K | 27.00K | 26.00K | 20.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.76M | 2.32M | 3.20M | 2.52M | 3.96M |
|
|
|||||
| Total Current Liabilities | 1.76M | 2.32M | 3.20M | 2.52M | 3.96M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 110.00K | 117.00K | 124.00K | 131.00K | 138.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 36.00K | 36.00K |
| Total Liabilities | 1.87M | 2.43M | 3.33M | 2.69M | 4.13M |
|
|
|||||
| Common Stock & APIC | 69.70M | 66.38M | 65.43M | 64.84M | 63.68M |
| Retained Earnings | -66.78M | -63.60M | -60.09M | -55.12M | -50.52M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 2.92M | 2.78M | 5.35M | 9.72M | 13.16M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.92M | 2.78M | 5.35M | 9.72M | 13.16M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.92M | 2.78M | 5.35M | 9.72M | 13.16M |
|
|
|||||